company background image
YTEN

Yield10 Bioscience NasdaqCM:YTEN Stock Report

Last Price

US$0.32

Market Cap

US$3.8m

7D

-13.9%

1Y

-90.3%

Updated

25 Sep, 2023

Data

Company Financials +

Yield10 Bioscience, Inc.

NasdaqCM:YTEN Stock Report

Mkt Cap: US$3.8m

YTEN Stock Overview

Yield10 Bioscience, Inc. operates as agricultural bioscience company in the United States.

YTEN fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Yield10 Bioscience, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Yield10 Bioscience
Historical stock prices
Current Share PriceUS$0.32
52 Week HighUS$4.19
52 Week LowUS$0.31
Beta1.82
1 Month Change-27.25%
3 Month Change-83.41%
1 Year Change-90.30%
3 Year Change-96.06%
5 Year Change-99.45%
Change since IPO-100.00%

Recent News & Updates

Recent updates

Yield10 Bioscience GAAP EPS of $0.70 beats by $1.39, revenue of $0.1M misses by $0.06M

Aug 10

Is Yield10 Bioscience (NASDAQ:YTEN) In A Good Position To Invest In Growth?

Nov 12
Is Yield10 Bioscience (NASDAQ:YTEN) In A Good Position To Invest In Growth?

Yield10 Bioscience (NASDAQ:YTEN) Is In A Good Position To Deliver On Growth Plans

Jul 19
Yield10 Bioscience (NASDAQ:YTEN) Is In A Good Position To Deliver On Growth Plans

Yield10 Bioscience, Inc.'s (NASDAQ:YTEN) CEO Will Probably Find It Hard To See A Huge Raise This Year

May 18
Yield10 Bioscience, Inc.'s (NASDAQ:YTEN) CEO Will Probably Find It Hard To See A Huge Raise This Year

Here's Why We're Watching Yield10 Bioscience's (NASDAQ:YTEN) Cash Burn Situation

Apr 14
Here's Why We're Watching Yield10 Bioscience's (NASDAQ:YTEN) Cash Burn Situation

Yield10 Bio secures $12.7M capital raise

Feb 01

Yield10 Bioscience under pressure on launching stock offering

Jan 29

When Will Yield10 Bioscience, Inc. (NASDAQ:YTEN) Become Profitable?

Jan 22
When Will Yield10 Bioscience, Inc. (NASDAQ:YTEN) Become Profitable?

We're Keeping An Eye On Yield10 Bioscience's (NASDAQ:YTEN) Cash Burn Rate

Nov 23
We're Keeping An Eye On Yield10 Bioscience's (NASDAQ:YTEN) Cash Burn Rate

Yield10 Bioscience, Inc. 2020 Q3 - Results - Earnings Call Presentation

Nov 13

Shareholder Returns

YTENUS BiotechsUS Market
7D-13.9%-1.8%-3.1%
1Y-90.3%10.3%15.1%

Return vs Industry: YTEN underperformed the US Biotechs industry which returned 10.3% over the past year.

Return vs Market: YTEN underperformed the US Market which returned 15.1% over the past year.

Price Volatility

Is YTEN's price volatile compared to industry and market?
YTEN volatility
YTEN Average Weekly Movement20.9%
Biotechs Industry Average Movement9.0%
Market Average Movement5.5%
10% most volatile stocks in US Market14.2%
10% least volatile stocks in US Market2.5%

Stable Share Price: YTEN is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 21% a week.

Volatility Over Time: YTEN's weekly volatility (21%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
199230Olly Peopleshttps://www.yield10bio.com

Yield10 Bioscience, Inc. operates as agricultural bioscience company in the United States. The company primarily focus on production of low carbon products through processing Camelina seeds. Its products include Camelina oil for low carbon biofuel feedstock; Omega-3 oils for nutrition; and PHA bioplastics for biodegradable zero waste packaging solutions.

Yield10 Bioscience, Inc. Fundamentals Summary

How do Yield10 Bioscience's earnings and revenue compare to its market cap?
YTEN fundamental statistics
Market CapUS$3.79m
Earnings (TTM)-US$14.25m
Revenue (TTM)US$258.00k

14.7x

P/S Ratio

-0.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
YTEN income statement (TTM)
RevenueUS$258.00k
Cost of RevenueUS$8.13m
Gross Profit-US$7.87m
Other ExpensesUS$6.38m
Earnings-US$14.25m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-1.20
Gross Margin-3,051.16%
Net Profit Margin-5,525.19%
Debt/Equity Ratio165.4%

How did YTEN perform over the long term?

See historical performance and comparison